| Gene symbol | CEACAM5 | Synonyms | CD66e, CEA | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | |
| Description | CEA cell adhesion molecule 5 | ||||
| GTO ID | GTC1164 |
| Trial ID | NCT00004178 |
| Disease | Cancer |
| Altered gene | CEA |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | CEA Ig TCR-T cells |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Phase I Study of T Cells Modified With Chimeric AntiCEA Immunoglobulin-T Cell Receptors (IgTCR) in Adenocarcinoma |
| Year | 2000 |
| Country | United States |
| Company sponsor | Roger Williams Medical Center |
| Other ID(s) | CDR0000067388|BIDMC-941101148|NEDH-941101148|NCI-V99-1577 |
| Cohort 1 | |||||||||
|
|||||||||